A detailed history of Platinum Investment Management LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Platinum Investment Management LTD holds 791 shares of JAZZ stock, worth $97,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares
791
Previous 930 14.95%
Holding current value
$97,269
Previous $99,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$100.57 - $116.37 $13,979 - $16,175
-139 Reduced 14.95%
791 $88,000
Q2 2024

Aug 12, 2024

BUY
$103.94 - $118.98 $11,329 - $12,968
109 Added 13.28%
930 $99,000
Q1 2024

May 13, 2024

BUY
$115.19 - $132.77 $14,283 - $16,463
124 Added 17.79%
821 $98,000
Q2 2023

Aug 10, 2023

BUY
$122.5 - $147.16 $9,922 - $11,919
81 Added 13.15%
697 $86,000
Q1 2023

May 11, 2023

BUY
$133.98 - $160.47 $82,531 - $98,849
616 New
616 $90,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.